Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins and progressive renal disease.

Michele Buemi1, Massimino Senatore, Francesco Corica

  • 1Department of Internal Medicine, University of Messina, Messina, Italy. Buemim@Unime.it

Medicinal Research Reviews
|December 18, 2001
PubMed
Summary

Statins, HMG-CoA reductase inhibitors, offer kidney protection beyond cholesterol reduction by inhibiting cell proliferation and inflammation. Further research is needed to confirm their potential in treating progressive renal disease in humans.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Congestion to Cardiorenal Protection: The New Therapeutic Balance Between SGLT2 Inhibitors and Loop Diuretics in Heart Failure.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same author

Correction: Polypharmacy and sarcopenia in hospitalized older patients: results of the GLISTEN study.

Aging clinical and experimental research·2025
Same author

Hemodialysis access creation in elderly patients: Strategic options.

The journal of vascular access·2025
Same author

Impact of SARS-CoV-2 Infection on Erythropoietin Resistance Index in Hemodialysis Patients.

Geriatrics (Basel, Switzerland)·2025
Same author

Controlling nutritional status score and geriatric nutritional risk index as a predictor of mortality and hospitalization risk in hospitalized older adults.

Nutrition (Burbank, Los Angeles County, Calif.)·2024
Same author

Proteinuria and Progression of Renal Damage: The Main Pathogenetic Mechanisms and Pharmacological Approach.

Medicina (Kaunas, Lithuania)·2024

Area of Science:

  • Nephrology
  • Pharmacology
  • Cell Biology

Background:

  • Progressive renal disease management has advanced with hypocholesterolemic drugs.
  • Statins (HMG-CoA reductase inhibitors) show promise in protecting against kidney diseases.

Purpose of the Study:

  • To investigate the protective effects of statins in progressive renal diseases.
  • To explore mechanisms of statin action independent of cholesterol reduction.

Main Methods:

  • In vitro and in vivo studies were conducted.
  • Evaluated statin effects on cell proliferation, inflammation, and signaling pathways.

Main Results:

  • Statins protect against kidney diseases like glomerulonephritis and IgA nephropathy.

Related Experiment Videos

  • Beneficial effects include inhibition of mesangial, tubular, and smooth muscle cell proliferation.
  • Statins modulate inflammation, reduce fibrosis, and affect cell proliferation/apoptosis balance.

    • Conclusions:

    • Statins possess pleiotropic effects beneficial for progressive renal disease, independent of lipid-lowering.
    • Mechanisms involve direct cellular effects and modulation of intracellular signaling pathways.
    • Further clinical studies are warranted to confirm statin efficacy in human progressive renal disease.